Lv51
1178 积分 2023-11-27 加入
Understanding the therapeutic toolkit for inflammatory bowel disease
1个月前
已完结
Sa1863 BETAINE ALLEVIATES GUT BARRIER INFLAMMATION VIA TLR4 SIGNALING AND LY6C+ MONOCYTES AND KUPFFER CELLS ORCHESTRATE LIVER IMMUNE RESPONES PREVENTS DSS INDUCED COLITIS AND ASSOCIATED LIVER INJURY
1个月前
已关闭
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
2个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
4个月前
已完结
The metabolic nature of inflammatory bowel diseases
4个月前
已完结
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases
5个月前
已完结
Host–microbiota interactions in inflammatory bowel disease
5个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
5个月前
已完结
应对炎症性肠病药物开发的复杂性
11个月前
已完结
基于聚合物的界面靶向溃疡性结肠炎的炎症
11个月前
已关闭
皖公网安备34019202002308
